| Value | Category | Cases | |
|---|---|---|---|
| 1 | Oral PrEP only | 158 |
74.9%
|
| 2 | 2 monthly Injectable (im) cabotegravir only | 52 |
24.6%
|
| 3 | DapiRing Only | 0 |
0%
|
| 4 | 6 monthly subcutaneous lenocapovir | 1 |
0.5%
|
| 5 | Oral PrEP and Injectable cabotegravir | 0 |
0%
|
| 96 | Other | 0 |
0%
|
| Sysmiss | 6810 |